Dipeptidyl Peptidase-4 Inhibitors in Diverse Patient Populations With Type 2 Diabetes

Purpose The purpose of this review is to discuss the clinical evidence for dipeptidyl peptidase-4 (DPP-4) inhibitors and to better define their use in treating type 2 diabetes mellitus (T2DM), including in special populations, such as the elderly. DPP-4 inhibitors are incretin-based therapies that c...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Diabetes educator 2015-12, Vol.41 (1_suppl), p.19S-31S
1. Verfasser:	Hinnen, Deborah
Format:	Artikel
Sprache:	eng
Schlagworte:	Age Factors Aged Aged, 80 and over Blood Glucose - drug effects Body Weight - drug effects Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - drug therapy Dipeptidyl-Peptidase IV Inhibitors - pharmacology Drug Therapy, Combination Glycated Hemoglobin A - drug effects Humans Hypoglycemia - chemically induced Hypoglycemic Agents - pharmacology Incretins - pharmacology Insulin - therapeutic use Kidney - drug effects Metformin - therapeutic use Nursing
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!